Low-dose naltrexone (LDN) is generating buzz as a potential treatment for a range of conditions, from chronic pain to autoimmune disorders, offering new hope for patients with difficult-to-manage ...
Neuroinflammation expert Jarred Younger, PhD, disputes a recent study commentary calling for clinicians to stop prescribing low-dose naltrexone for people with fibromyalgia. Naltrexone is a ...
SALT LAKE CITY, March 4, 2025 /PRNewswire/ -- Shed, a telehealth clinic specializing in weight loss, is excited to announce the launch of Low-Dose Naltrexone (LDN), an innovative, therapeutic solution ...
But study's observational design and lack of a control group limit the findings' impact ...